Gefitinib: A Revolutionary EGFR Inhibitor for Cancer Treatment
Lung cancer remains one of the most aggressive and fatal cancers worldwide, with non-small cell lung cancer (NSCLC) accounting for...
Read moreLung cancer remains one of the most aggressive and fatal cancers worldwide, with non-small cell lung cancer (NSCLC) accounting for...
Read more